×
About 36,465 results

ALLMedicine™ Hepatitis B Center

Research & Reviews  12,819 results

Liver stiffness measured with two-dimensional shear wave elastography comparable to his...
https://doi.org/10.3233/CH-211223
Clinical Hemorheology and Microcirculation; Li Y, Wu S

Aug 3rd, 2021 - Two-dimensional shear-wave elastography (2D-SWE) has been used for years for liver assessment of patients with chronic hepatitis B (CHB), but its effectiveness remains unclear in different populations and using different ultrasound systems. This s...

The Evaluation of Hepatitis B Screening and Reactivation in Patients Receiving Rituxima...
https://doi.org/10.1111/ijcp.14685
International Journal of Clinical Practice; Bozkurt I, Ozturk Cerik H et. al.

Aug 1st, 2021 - Hepatitis B virus (HBV) infection is a worldwide distributing viral disease. Hepatitis due to HBV reactivation may progress to chronic illness and associated with increased risk of hepatic failure and hepatocellular cancer. Rituximab (RTX) is an i...

The trend of direct medical costs and associated factors in patients with chronic hepat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323196
BMC Medical Informatics and Decision Making; Yang S, Chen G et. al.

Aug 1st, 2021 - Although the expenses of liver cirrhosis are covered by a critical illness fund under the current health insurance program in China, the medical costs associated with hepatitis B virus (HBV) related diseases is not well addressed. In order to prov...

Functional cure of chronic hepatitis B - predictable?
https://doi.org/10.1016/j.ebiom.2021.103499
EBioMedicine Gerlich W

Aug 1st, 2021 - Functional cure of chronic hepatitis B - predictable?|2021|Gerlich W,|

see more →

Guidelines  40 results

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Sta...
https://www.ncbi.nlm.nih.gov/pubmed/33856166
American Family Physician;

Apr 16th, 2021 - Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Statement.|2021||blood,diagnosis,prevention & control,blood,diagnosis,prevention & control,

Guideline No. 409: Intrauterine Fetal Diagnostic Testing in Women with Chronic Viral In...
https://doi.org/10.1016/j.jogc.2020.09.007
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Wilson RD

Dec 15th, 2020 - This revised guideline provides updated information for the care of women with chronic viral infections who require intrauterine fetal diagnostic testing. Women with chronic viral infections who are pregnant or planning a pregnancy. Non-invasive s...

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: A...
https://doi.org/10.1200/JCO.20.01757
Journal of Clinical Oncology : Official Journal of the Am... Hwang JP, Feld JJ et. al.

Jul 28th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

see more →

Drugs  131 results see all →

Clinicaltrials.gov  605 results

HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)
https://clinicaltrials.gov/ct2/show/NCT03685708

May 1st, 2020 - This study aims to determine the HEPLISAV-B hepatitis B vaccine efficacy in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) lymphocytic patients that are treatment naive or receiving Bruton s-tyrosine kinase inhibitor (BTK-...

Oral Microbiome of Patients With Hepatitis C Virus Infection
https://clinicaltrials.gov/ct2/show/NCT03682549

Apr 24th, 2020 - Human oral cavity is a great habitat for more than 600 species of bacteria, known as oral microbiota, living in equilibrium. Oral microbiota plays an important role in maintaining oral health; however when the balance in oral bacterial population ...

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
https://clinicaltrials.gov/ct2/show/NCT03383419

Apr 24th, 2020 - utilizing HCV-positive donors (defined as HCV-NAT positive) for heart transplantation in HCV-negative recipients treated with Epclusa®. Subjects will be identified from the heart transplantation waitlist. Subjects who, according to the judgement o...

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
https://clinicaltrials.gov/ct2/show/NCT01350648

Apr 20th, 2020 - Chronic viral hepatitis is a major health problem affecting millions globally. The immunosuppressed population, especially those with HIV infection, remains at particular risk and the incidence of hepatocellular carcinoma (HCC) is increasing in th...

An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
https://clinicaltrials.gov/ct2/show/NCT03361956

Apr 15th, 2020 - The main study consists of 2-parts and each part will consist of 2 types of Chronic Hepatitis B-infected participant populations. Each part of the study will consist of screening phase (up to 8 weeks), treatment phase (24 weeks or 48 weeks, depend...

see more →

News  963 results

New Antiviral Drug Promising Against HBV
https://www.medscape.com/viewarticle/955063

Jul 21st, 2021 - NEW YORK (Reuters Health) - RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator, appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study. "These results provide p...

Protein Expression May Predict HBV DNA Suppression
https://www.medscape.com/viewarticle/954484

Jul 8th, 2021 - Stopping nucleoside analog therapy in patients with hepatitis B viral (HBV) infections results in sustained viral suppression in only a minority of patients, but a new study suggests there are immune signatures that may serve as predictive biomark...

UK COVID-19 Update: Mandatory NHS Jabs Considered, 'Exciting' Antibody Treatment Results
https://www.medscape.com/viewarticle/953175

Jun 16th, 2021 - Editor's note, 16 June 2021: This article was updated with new information from the Commons. These are the UK coronavirus stories you need to know about today. Mandatory Jabs The Guardian reported there are plans for COVID-19 vaccination to be mad...

Tri-antigenic Vaccine Prevents HBV Infection in Adults
https://www.medscape.com/viewarticle/952116

Jun 1st, 2021 - NEW YORK (Reuters Health) - A tri-antigenic hepatitis B vaccine (TAV) effectively prevented hepatitis B virus (HBV) infection in adults, was somewhat more effective than a mono-antigenic vaccine (MAV) comparator, but had higher side effect rates i...

SciClone Pharma Tests Hepatitis Drug as COVID-19 Vaccine Enhancer
https://www.medscape.com/viewarticle/949926

Apr 27th, 2021 - BEIJING (Reuters) - China's SciClone Pharmaceuticals has begun a clinical trial to test if its hepatitis B treatment Zadaxin helps to boost immunity provided by COVID-19 vaccines, it said on Monday. SciClone said it is using an inactivated COVID-1...

see more →

Patient Education  28 results see all →